🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.710
-0.100 (-5.52%)
At close: Nov 20, 2026, 4:00 PM EST
1.709
-0.001 (-0.06%)
After-hours: Nov 20, 2026, 7:50 PM EST

TherapeuticsMD Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.753.021.761.369.962.57
Revenue Growth
33.94%71.61%35.25%-98.14%2619.12%-96.03%
Cost of Revenue
----1.41.4
Gross Profit
3.753.021.761.368.571.17
Selling, General & Admin
4.785.014.748.956.7172.75
Operating Expenses
5.165.395.259.8357.972.75
Operating Income
-1.41-2.37-3.49-8.5210.66-71.58
Interest & Investment Income
0.240.140.14---
Other Non Operating Income (Expenses)
1.431.752.280.78-0.120.27
EBT Excluding Unusual Items
0.26-0.48-1.08-7.7410.55-71.31
Merger & Restructuring Charges
-----9.47-
Asset Writedown
-0.07-0.18-1.27---
Other Unusual Items
------8
Pretax Income
0.19-0.65-2.34-7.741.07-79.31
Income Tax Expense
0.03--0.03-0.04--
Earnings From Continuing Operations
0.16-0.65-2.31-7.71.07-79.31
Earnings From Discontinued Operations
-0.030.080.13-2.58110.92-93.11
Net Income
0.12-0.57-2.18-10.28112-172.42
Net Income to Common
0.12-0.57-2.18-10.28112-172.42
Net Income Growth
-59.60%-----
Shares Outstanding (Basic)
1212121098
Shares Outstanding (Diluted)
1212121098
Shares Change
0.59%0.32%10.45%11.48%17.66%44.39%
EPS (Basic)
0.01-0.05-0.19-0.9812.41-21.66
EPS (Diluted)
0.01-0.05-0.19-0.9911.95-21.66
EPS Growth
-59.66%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3.332.420.73-48.14-4.08-142.73
Free Cash Flow Per Share
0.290.210.06-4.61-0.43-17.93
Gross Margin
100.00%100.00%100.00%100.00%98.00%45.51%
Operating Margin
-37.73%-78.33%-198.30%-654.61%15.24%-2781.85%
Profit Margin
3.26%-18.83%-123.85%-789.40%160.08%-6700.93%
Free Cash Flow Margin
88.97%80.21%41.57%-3697.46%-5.83%-5547.10%
EBITDA
-1.03-1.98-2.98-8.0811.86-70.84
EBITDA Margin
-27.50%-65.62%-169.39%-16.95%-
D&A For EBITDA
0.380.380.510.441.190.74
EBIT
-1.41-2.37-3.49-8.5210.66-71.58
EBIT Margin
-37.73%-78.33%-198.30%-15.24%-
Revenue as Reported
----69.962.57
SEC Filings: 10-K · 10-Q